Penile cancer

Peter E. Clark, Philippe E. Spiess, Neeraj Agarwal, Matthew C. Biagioli, Mario A. Eisenberger, Richard E. Greenberg, Harry W. Herr, Brant A. Inman, Deborah A. Kuban, Timothy M. Kuzel, Subodh M. Lele, Jeff Michalski, Lance Pagliaro, Sumanta K. Pal, Anthony Patterson, Elizabeth R. Plimack, Kamal S. Pohar, Michael P. Porter, Jerome P. Richie, Wade J. SextonWilliam U. Shipley, Eric J. Small, Donald L. Trump, Geoffrey Wile, Timothy G. Wilson, Mary Dwyer, Maria Ho

Research output: Contribution to journalArticlepeer-review

158 Scopus citations

Abstract

Squamous cell carcinoma of the penis represents approximately 0.5% of all cancers among men in the United States and other developed countries. Although rare, it is associated with significant disfigurement, and only half of the patients survive beyond 5 years. Proper evaluation of both the primary lesion and lymph nodes is critical, because nodal involvement is the most important factor of survival. The NCCN Clinical Practice Guidelines in Oncology for Penile Cancer provide recommendations on the diagnosis and management of this devastating disease based on evidence and expert consensus.

Original languageEnglish
Pages (from-to)594-615
Number of pages22
JournalJournal of the National Comprehensive Cancer Network : JNCCN
Volume11
Issue number5
DOIs
StatePublished - May 1 2013

Keywords

  • Follow-Up Studies
  • Humans
  • Male
  • Neoplasm Metastasis
  • Neoplasm Staging
  • Penile Neoplasms/diagnosis
  • Recurrence
  • Risk Factors

Fingerprint

Dive into the research topics of 'Penile cancer'. Together they form a unique fingerprint.

Cite this